Related Experiment Video
Updated: Oct 10, 2025
06:53
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
8.8K
Evidence-Based Minireview: Molecular precision and clinical uncertainty: should molecular profiling be routinely used
Daniel R Richardson1, Amy E DeZern2
1Division of Hematology, Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.
Hematology. American Society of Hematology. Education Program
|December 10, 2021
Abstract:
This is a focused clinical vignette and review of the literature in MDS to discuss the application of molecular sequencing for risk stratification in MDS. The authors utilize an exemplar patient case and explain the advantages and disadvantages, based on available data, of routine use of this testing for MDS patients.
